Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha
P Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers
|
April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer
S Barni, P Lissoni, D Mandelli, et al.
Tumori
|
August 31, 1994
Vinorelbine as single agent in pretreated patients with advanced breast cancer
S Barni, A Ardizzoia, G Bernardo, et al.
Anticancer Research
|
May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer
P Lissoni, S Barni, C Archili, et al.
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
The International Journal of Biological Markers
|
July 1, 1989
Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlated
P Lissoni, V Rizzo, S Barni, et al.
The International Journal of Biological Markers
|
October 1, 1990
Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome
P Lissoni, S Barni, G Cattaneo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancer
P Lissoni, A L Sormani, G Tancini, et al.
Oncology
|
January 1, 1992
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha
P Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers
|
April 1, 1991
Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer
S Barni, P Lissoni, D Mandelli, et al.
Tumori
|
August 31, 1994
Vinorelbine as single agent in pretreated patients with advanced breast cancer
S Barni, A Ardizzoia, G Bernardo, et al.
Anticancer Research
|
May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer
P Lissoni, S Barni, C Archili, et al.
Anticancer Research
|
November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
P Lissoni, F Brivio, S Barni, et al.
The International Journal of Biological Markers
|
July 1, 1989
Interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors in patients with solid tumors are not correlated
P Lissoni, V Rizzo, S Barni, et al.
The International Journal of Biological Markers
|
October 1, 1990
Activation of the complement system during immunotherapy of cancer with interleukin-2: a possible explanation of the capillary leak syndrome
P Lissoni, S Barni, G Cattaneo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancer
P Lissoni, A L Sormani, G Tancini, et al.
Oncology
|
January 1, 1992
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 2